Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of XL999 in Patients With Acute Myeloid Leukemia (AML)

This study has been terminated.
(Study was terminated due to cardiac toxicities)
Information provided by:
Symphony Evolution, Inc. Identifier:
First received: May 4, 2006
Last updated: February 18, 2010
Last verified: February 2010
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2007
  Primary Completion Date: November 2006 (Final data collection date for primary outcome measure)